Bausch Health Companies (BHC) Depreciation & Amortization (CF) (2009 - 2026)

Bausch Health Companies has disclosed Depreciation & Amortization (CF) across 18 years of filings, most recently posting $295.0 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $295.0 million, down 3.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 4.31% YoY), and the FY2025 annual result was $1.2 billion, down 4.66% from the prior year.
• Depreciation & Amortization (CF) came in at $295.0 million for Q1 2026 at Bausch Health Companies, up from $290.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $360.0 million in Q4 2022 to a low of $290.0 million in Q4 2025.
• The 5-year median for Depreciation & Amortization (CF) is $318.0 million (2024), against an average of $319.3 million.
• Across the five-year window, Depreciation & Amortization (CF) decreased 14.11% in 2022 and advanced 6.98% in 2024, its largest moves.
• Bausch Health Companies' Depreciation & Amortization (CF) stood at $360.0 million in 2022, then slipped by 8.61% to $329.0 million in 2023, then dropped by 6.69% to $307.0 million in 2024, then slipped by 5.54% to $290.0 million in 2025, then advanced by 1.72% to $295.0 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $295.0 million (Q1 2026), $290.0 million (Q4 2025), and $306.0 million (Q3 2025), per Business Quant data.